About Bioextrax
Bioextrax is a company based in Lund (Sweden) founded in 2014. Bioextrax offers products and services including PHA Extraction Technology, Organic Hydrolyzed Protein, and Keratin Microfibres. Bioextrax operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Lund, Sweden
-
Sectors
HealthcareTechnology Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioextrax Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$95.57 K (USD), Grant
Jun 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioextrax
Bioextrax offers a comprehensive portfolio of products and services, including PHA Extraction Technology, Organic Hydrolyzed Protein, and Keratin Microfibres.
Bio-based method to extract PHA from sucrose for sustainable plastics.
Converts feathers into protein hydrolysate for animal feed applications.
Transforms feathers into microfibres for composites and textiles uses.
People of Bioextrax
Unlock access to complete
Funding Insights of Bioextrax
Investors in Bioextrax
Bioextrax has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Bioextrax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioextrax
Investment portfolio details for Bioextrax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioextrax
Detailed financials for Bioextrax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioextrax Comparisons
Peer comparison for Bioextrax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioextrax
Bioextrax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Bioextrax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioextrax
Complete news archive for Bioextrax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioextrax
Bioextrax was founded in 2014 and raised its 1st funding round 8 years after it was founded.
Bioextrax is headquartered in Lund, Sweden.
Bioextrax has developed a technology, which uses a microbial strain to extract PHA granules from PHA-producing bacteria. The technology uses mild lysis of the microbial cell wall to extract a proprietary isolate from the microbe. The isolate, in turn, extracts PHA granules from the bacteria and produces a by-product protein hydrolysate. Also, the company claims that the by-products and the microbial isolate can be used for several other things.
Bioextrax's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Bioextrax offers PHA Extraction Technology, Organic Hydrolyzed Protein, and Keratin Microfibres.
Bioextrax has 1 investor. Key investors include European Union.